Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal s6 kinase (p90RSK)

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Lucien, Fabrice ^a   Brochu Gaudreau, Karine ^a   Arsenault, Dominique ^a   Harper, Kelly ^a   Dubois, Claire M ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; S6 KINASE; SHORT HAIRPIN RNA; SODIUM PROTON EXCHANGE PROTEIN 1; CATION TRANSPORT PROTEIN; PRIMER DNA; SLC9A1 PROTEIN, HUMAN; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL HYPOXIA; CELL INVASION; CELL MEMBRANE; CELL PH; CONTROLLED STUDY; HUMAN; HUMAN CELL; INVADOPODIUM; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; TUMOR MICROENVIRONMENT; METABOLISM; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BASE SEQUENCE; CATION TRANSPORT PROTEINS; CELL HYPOXIA; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SODIUM-HYDROGEN ANTIPORTER;

EID: 84455170179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028851     Document Type: Article

References (74)

1. Finger EC, Giaccia AJ, (2010) Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 29: 285-293.
2. Parks SK, Chiche J, Pouyssegur J, (2011) pH control mechanisms of tumor survival and growth. J Cell Physiol 226: 299-308.
3. Ruan K, Song G, Ouyang G, (2009) Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107: 1053-1062.
4. Hockel M, Schlenger K, Hockel S, Vaupel P, (1999) Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59: 4525-4528.
5. Hockel M, Vaupel P, (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276.
6. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, Moreno-Sanchez R, (2009) HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084-1101.
7. McCarty MF, Whitaker J, (2010) Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev 15: 264-272.
8. Wike-Hooley JL, Van der Zee J, van Rhoon GC, Van den Berg AP, Reinhold HS, (1984) Human tumour pH changes following hyperthermia and radiation therapy. Eur J Cancer Clin Oncol 20: 619-623.
9. Kallinowski F, Schlenger KH, Kloes M, Stohrer M, Vaupel P, (1989) Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int J Cancer 44: 266-272.
10. Griffiths JR, (1991) Are cancer cells acidic? Br J Cancer 64: 425-427.
11. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM, (2002) MRI of the tumor microenvironment. J Magn Reson Imaging 16: 430-450.
12. Xu L, Fukumura D, Jain RK, (2002) Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 277: 11368-11374.
13. Xu L, Fidler IJ, (2000) Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res 60: 4610-4616.
14. Rofstad EK, Mathiesen B, Kindem K, Galappathi K, (2006) Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66: 6699-6707.
15. Stock C, Cardone RA, Busco G, Krahling H, Schwab A, et al. (2008) Protons extruded by NHE1: digestive or glue? Eur J Cell Biol 87: 591-599.
16. Taves J, Rastedt D, Canine J, Mork D, Wallert MA, et al. (2008) Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts. Arch Biochem Biophys 477: 60-66.
17. Bourguignon LY, Singleton PA, Diedrich F, Stern R, Gilad E, (2004) CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 279: 26991-27007.
18. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, et al. (2009) Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 69: 2260-2268.
19. Kinsella JL, Heller P, Froehlich JP, (1998) Na+/H+ exchanger: proton modifier site regulation of activity. Biochem Cell Biol 76: 743-749.
20. Reshkin SJ, Bellizzi A, Caldeira S, Albarani V, Malanchi I, et al. (2000) Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 14: 2185-2197.
21. Steffan JJ, Snider JL, Skalli O, Welbourne T, Cardelli JA, (2009) Na+/H+ exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells. Traffic 10: 737-753.
22. Paradiso A, Cardone RA, Bellizzi A, Bagorda A, Guerra L, et al. (2004) The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Breast Cancer Res 6: R616-628.
23. Putney LK, Barber DL, (2004) Expression profile of genes regulated by activity of the Na-H exchanger NHE1. BMC Genomics 5: 46.
24. Busco G, Cardone RA, Greco MR, Bellizzi A, Colella M, et al. (2010) NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J 24: 3903-3915.
25. Baumgartner M, Patel H, Barber DL, (2004) Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am J Physiol Cell Physiol 287: C844-850.
26. Takahashi E, Abe J, Gallis B, Aebersold R, Spring DJ, et al. (1999) p90(RSK) is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory phosphorylation of serine 703 of Na+/H+ exchanger isoform-1. J Biol Chem 274: 20206-20214.
27. Coopman PJ, Do MT, Thompson EW, Mueller SC, (1998) Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 4: 507-515.
28. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, et al. (1994) A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 54: 5702-5710.
29. Chen WT, (1996) Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49: 59-71.
30. Buccione R, Caldieri G, Ayala I, (2009) Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 28: 137-149.
31. Kimura F, Iwaya K, Kawaguchi T, Kaise H, Yamada K, et al. (2010) Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast. Cancer Sci 101: 1133-1140.
32. Harper K, Arsenault D, Boulay-Jean S, Lauzier A, Lucien F, et al. (2010) Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation. Cancer Res 70: 4634-4643.
33. Mandal S, Johnson KR, Wheelock MJ, (2008) TGF-beta induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways. Exp Cell Res 314: 3478-3493.
34. Shimoda LA, Fallon M, Pisarcik S, Wang J, Semenza GL, (2006) HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol 291: L941-949.
35. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC, (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66: 3034-3043.
36. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, et al. (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160: 267-277.
37. Denker SP, Barber DL, (2002) Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1. J Cell Biol 159: 1087-1096.
38. Denker SP, Huang DC, Orlowski J, Furthmayr H, Barber DL, (2000) Direct binding of the Na-H exchanger NHE1 to ERM proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation. Mol Cell 6: 1425-1436.
39. Schwab A, Hanley P, Fabian A, Stock C, (2008) Potassium channels keep mobile cells on the go. Physiology (Bethesda) 23: 212-220.
40. Garciarena CD, Caldiz CI, Portiansky EL, Chiappe de Cingolani GE, Ennis IL, (2009) Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart. J Appl Physiol 106: 1325-1331.
41. Spring DJ, Krebs EG, (1999) Deletion of 11 amino acids in p90(rsk-mo-1) abolishes kinase activity. Mol Cell Biol 19: 317-320.
42. Bertout JA, Patel SA, Simon MC, (2008) The impact of O2 availability on human cancer. Nat Rev Cancer 8: 967-975.
43. Stock C, Schwab A, (2009) Protons make tumor cells move like clockwork. Pflugers Arch 458: 981-992.
44. Yang X, Wang D, Dong W, Song Z, Dou K, (2010) Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett 295: 198-204.
45. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, et al. (2007) Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18: 4691-4697.
46. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, et al. (2007) Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761.
47. Park YK, Park H, (2010) Prevention of CCAAT/enhancer-binding protein beta DNA binding by hypoxia during adipogenesis. J Biol Chem 285: 3289-3299.
48. Wouters BG, Koritzinsky M, (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8: 851-864.
49. Wenger RH, (2002) Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 16: 1151-1162.
50. Seko Y, Tobe K, Takahashi N, Kaburagi Y, Kadowaki T, et al. (1996) Hypoxia and hypoxia/reoxygenation activate Src family tyrosine kinases and p21ras in cultured rat cardiac myocytes. Biochem Biophys Res Commun 226: 530-535.
51. Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, et al. (2007) ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Lab Invest 87: 1149-1158.
52. Mizukami Y, Fujiki K, Duerr EM, Gala M, Jo WS, et al. (2006) Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J Biol Chem 281: 13957-13963.
53. Frodin M, Gammeltoft S, (1999) Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151: 65-77.
54. Clark DE, Errington TM, Smith JA, Frierson HF Jr, Weber MJ, et al. (2005) The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res 65: 3108-3116.
55. Smith JA, Poteet-Smith CE, Xu Y, Errington TM, Hecht SM, et al. (2005) Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res 65: 1027-1034.
56. Romeo Y, Roux PP, (2011) Paving the way for targeting RSK in cancer. Expert Opin Ther Targets 15: 5-9.
57. Woo MS, Ohta Y, Rabinovitz I, Stossel TP, Blenis J, (2004) Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site. Mol Cell Biol 24: 3025-3035.
58. Lee E, Yim S, Lee SK, Park H, (2002) Two transactivation domains of hypoxia-inducible factor-1alpha regulated by the MEK-1/p42/p44 MAPK pathway. Mol Cells 14: 9-15.
59. Liu L, Zhang H, Sun L, Gao Y, Jin H, et al. (2010) ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer. Int J Cancer 127: 820-829.
60. Mishra OP, Ashraf QM, Delivoria-Papadopoulos M, (2010) Hypoxia-induced activation of epidermal growth factor receptor (EGFR) kinase in the cerebral cortex of newborn piglets: the role of nitric oxide. Neurochem Res 35: 1471-1477.
61. Tekpli X, Huc L, Lacroix J, Rissel M, Poet M, et al. (2008) Regulation of Na+/H+ exchanger 1 allosteric balance by its localization in cholesterol- and caveolin-rich membrane microdomains. J Cell Physiol 216: 207-220.
62. Caldieri G, Giacchetti G, Beznoussenko G, Attanasio F, Ayala I, et al. (2009) Invadopodia biogenesis is regulated by caveolin-mediated modulation of membrane cholesterol levels. J Cell Mol Med 13: 1728-1740.
63. Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, et al. (2009) Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res 69: 8594-8602.
64. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
65. Avkiran M, Cook AR, Cuello F, (2008) Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? Curr Opin Pharmacol 8: 133-140.
66. Corvera JS, Zhao ZQ, Schmarkey LS, Katzmark SL, Budde JM, et al. (2003) Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury. Ann Thorac Surg 76: 1614-1622.
67. Karmazyn M, Sostaric JV, Gan XT, (2001) The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 61: 375-389.
68. Maekawa N, Abe J, Shishido T, Itoh S, Ding B, et al. (2006) Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury. Circulation 113: 2516-2523.
69. Rios EJ, Fallon M, Wang J, Shimoda LA, (2005) Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 289: L867-874.
70. Yu L, Quinn DA, Garg HG, Hales CA, (2008) Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med 177: 1276-1284.
71. Chomczynski P, (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-534, 536-537.
72. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, et al. (2001) Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J Biol Chem 276: 33986-33994.
73. Arsenault D, Lucien F, Dubois CM, (2011) Hypoxia enhances cancer cell invasion through relocalization of the proprotein convertase furin from the trans-Golgi network to the cell surface. J Cell Physiol.
74. Manders EMM, Verbeek FJ, Aten JA, (1993) Measurement of co-localization of objects in dual color confocal images. Journal of Microscopy 169: 375-382.